Thyme Care’s Series D round included participation from CVS Health Ventures, Foresite Capital, Morgan Health and Humana. In total, it has raised $275 million.
The post Thyme Care Banks $97M to Accelerate Value-Based Cancer Care appeared first on MedCity News.
